Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epitizide is a benzothiadiazine diuretic, often used in combination with other agents like triamterene. Its primary mechanism of action involves inhibiting the sodium-chloride cotransporter (NCC) located in the distal convoluted tubule of the kidneys. This inhibition reduces the reabsorption of sodium and chloride ions, leading to increased urinary excretion of these electrolytes and water, thereby promoting diuresis. Epitizide is employed in the management of conditions characterized by fluid retention and hypertension.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Epitizide.